Florida accuses Planned Parenthood of racketeering over chemical abortion marketing, seeking massive damages in unprecedented ...

Guo Xin, a marketing professor at Beijing Technology and Business University, said that as the Healthy China 2030 strategy ...

In today’s Pharmaceutical Executive Daily, we cover Eli Lilly and Novo Nordisk’s plans to bring their leading weight-loss medications to the TrumpRx platform, the State of Texas’ legal move to block ...

Texas AG Paxton is taking legal action to stop Kenvue from issuing dividends, potentially affecting Tylenol lawsuit funds.

The lawsuit was initially filed in Panola County. Attorneys representing Johnson and Johnson and Kenvue filed a notice this ...

Ken Paxton, Texas Attorney General, has sued Kenvue, the current manufacturer of Tylenol, and its former parent company ...

Texas files 2nd lawsuit against Tylenol makers seeking to block $400M dividend over alleged deceptive marketing and liability concerns.

Kimberly-Clark Corporation (NASDAQ:KMB)’s $48.7 billion Kenvue acquisition announcement was well-received by Jim Cramer ...

Andrew Slimmon, Senior Portfolio Manager at Morgan Stanley Investment Management, discussed broader market trends on CNBC, ...

The filing is likely intended to create financial uncertainty for the company — something Texas has promised corporations ...

Texas Attorney General Ken Paxton has asked a federal judge to force the makers of Tylenol to stop any advertising that the ...

The Texas Office of Attorney General, or OAG, asked a Panola County court on Wednesday to block a Texas company from paying ...